Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation |
|---|
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
The purpose of this study is to understand how to develop and deliver a better smoking cessation program for lower-income young adult smokers.
Description: Self-reported smoking abstinence and biochemical validation (saliva cotinine)
Measure: 30-day point prevalence smoking abstinence Time: Assessed at 3-month follow-upDescription: Confidence to quit within the next month (7days) on 0-10 scale
Measure: Self-efficacy to quit smoking Time: Assessed at 3-month follow-upDescription: Completing 75% or more of 12 weekly check-ins
Measure: Intervention engagement Time: 12 weeksDescription: Self-reported smoking abstinence
Measure: 7-day point prevalence smoking abstinence Time: Assessed at 3-month follow-upDescription: Number of times intentionally stopped smoking cigarettes for 24 hours or longer because trying to quit
Measure: Number of 24-hour quit attempts Time: Assessed at 3-month follow-upDescription: 4 items pertaining to quit support from the text messages
Measure: Perceived support to quit smoking Time: Assessed 3-month follow-upDescription: Past 30 (90 day) use of tobacco or nicotine products such as cigars, e-cigarettes, chewing tobacco, and nicotine replacement products
Measure: Pattern and rate of tobacco/e-cigarette use Time: Assessed at 3-month follow-upAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports